News for 'Nuvama'

State Bank of India led MF buys in July with Rs 10,000 crore QIP bet

State Bank of India led MF buys in July with Rs 10,000 crore QIP bet

Rediff.com16 Aug 2025

Mutual funds (MFs) - flush with cash amid record inflows in July - invested heavily in the Rs 25,000-crore qualified institutional placement (QIP) of India's largest lender State Bank of India (SBI). Fund managers acquired SBI shares worth Rs 10,200 crore last month, making the lender their biggest buy in July.

Jane Street Officials To Meet Sebi Soon

Jane Street Officials To Meet Sebi Soon

Rediff.com3 Sep 2025

'The hearing is not adversarial but inquisitorial in nature -- it allows Sebi to examine the context, the strategy, and the intent behind the trades, particularly when algorithmic and expiry-day trading are involved.'

Jio's Rs 30,000 Cr IPO: India's Largest

Jio's Rs 30,000 Cr IPO: India's Largest

Rediff.com2 Sep 2025

Reliance holds 67.03% of Jio Platforms Limited and the public listing would provide an exit to many investors.

Trump Tariffs: Time To Rejig Portolio

Trump Tariffs: Time To Rejig Portolio

Rediff.com4 Apr 2025

Investors should tilt their portfolios towards domestic-facing defensive sectors, which should help provide stability and shield them from geopolitical and tariff risks.

Shares of MIIs, brokerages decline as concerns rise over threat to volumes

Shares of MIIs, brokerages decline as concerns rise over threat to volumes

Rediff.com13 Jul 2025

Stocks of brokerages and market infrastructure institutions (MIIs) witnessed selling pressure after the Securities and Exchange Board of India's (Sebi's) crackdown on proprietary trading firm Jane Street. The weakness was attributed to concerns that debarment of the US firm - a prominent player in the futures and options (F&O) segment - will lead to a further decline in volumes, which are already down over 30 per cent from the peak.

Defence stocks on growth warpath as order blitz fuels bullish outlook

Defence stocks on growth warpath as order blitz fuels bullish outlook

Rediff.com12 May 2025

Defence stocks have been on a tear, with the Nifty India Defence index hitting all-time highs. Over the past week, the index jumped around 7 per cent, far outpacing the flat performance of the Nifty 50. Over the past month, its 12 per cent gain has trebled the benchmark's return.

Flip in derivatives expiry days: NSE to shift to Tuesday, BSE gets Thursday

Flip in derivatives expiry days: NSE to shift to Tuesday, BSE gets Thursday

Rediff.com18 Jun 2025

In a move that could have implications for market share dynamics, the Securities and Exchange Board of India (Sebi) has permitted the National Stock Exchange (NSE) and the BSE to alter the days for settlement of equity derivatives contracts.

Passive funds have to sell Rs 1.5K crore ITC Hotels shares after listing

Passive funds have to sell Rs 1.5K crore ITC Hotels shares after listing

Rediff.com8 Jan 2025

Domestic passive mutual fund (MF) schemes will have to sell around Rs 1,500 crore worth of ITC Hotels shares once the demerged entity lists on the exchanges, according to estimates. Passive MF schemes - especially those tracking the Nifty 50 and Sensex - will have to offload their holdings in ITC Hotels as the stock will be excluded from the indices.

National interest is our top priority: JioStar

National interest is our top priority: JioStar

Rediff.com9 May 2025

Firmly committed to prioritise national interest over all other considerations: JioStar

Dr Reddy's faces Revlimid cliff, analysts split on future growth prospects

Dr Reddy's faces Revlimid cliff, analysts split on future growth prospects

Rediff.com26 Jan 2025

Dr Reddy's Laboratories (DRL) share price plunged 6.66 per cent to Rs 1,203.50 per share on the NSE during Friday after analysts remained cautious on the company's Q3 performance and differed on its growth outlook. DRL's Q3 performance was viewed as subdued by some analysts when they adjusted it for one-time grants and incomes that the company received during the quarter.

Lock-up on nearly Rs 1.2 trillion pre-IPO shares to lift in two months

Lock-up on nearly Rs 1.2 trillion pre-IPO shares to lift in two months

Rediff.com2 Dec 2024

Lock up on shares worth nearly Rs 1.2 trillion ($14 billion) belonging to 50 companies will end between now and January 31, said Nuvama Institutional Equities in a note. Most of the shares are held by promoters, strategic investors or pre-listing shareholders in companies that have gone public in recent weeks or months.

'Bharti AXA's First Goal Is To Achieve 3x Revenue'

'Bharti AXA's First Goal Is To Achieve 3x Revenue'

Rediff.com11 Jun 2025

'Our new business premium is around Rs 700 crore, which we want to take to Rs 2,000 crore.'

Bangladesh Unrest Hits India's Medical Tourism

Bangladesh Unrest Hits India's Medical Tourism

Rediff.com12 Jun 2025

Revenues from Bangladeshi patients have declined by 30% to 35% in 2024-2025. Bangladesh typically accounts for 70% to 75% of all medical visas issued by India.

Most brokerages upbeat on Info Edge's outlook after strong Q3 results

Most brokerages upbeat on Info Edge's outlook after strong Q3 results

Rediff.com7 Feb 2025

Info Edge (India) topped expectations in its October-December quarter (Q3) results, posting strong revenue and profit growth. Its shares have rallied as much as 6.14 per cent in two days. The technology holding company's revenue rose 15.2 per cent year-on-year (Y-o-Y) to Rs 722.3 crore, driven by robust performance across its key verticals, particularly its recruitment business.

TaMo in driver's seat to combat headwinds

TaMo in driver's seat to combat headwinds

Rediff.com20 Mar 2025

Automobile giant Tata Motors' shares were in demand on Wednesday as the stock rallied as much as 3.69 per cent to hit an intraday high of Rs 671.80 per share, before settling 3.18 per cent higher at Rs 668.45. By comparison, the BSE Sensex settled 0.10 per cent, or 72.56 points, lower at 74,029.76.

Most active equity funds beat benchmarks

Most active equity funds beat benchmarks

Rediff.com29 Apr 2025

Majority of equity fund managers were able to squeeze in some extra returns over their benchmarks in 2024-25 (FY25). While some managed to do so by delivering outsized returns during the equity market rally in the first half of the year (H1FY25), others succeeded by limiting the downside during the market downturn.

Large-cap cut-off surpasses Rs 1 trillion as 11 new stocks join the list

Large-cap cut-off surpasses Rs 1 trillion as 11 new stocks join the list

Rediff.com7 Jan 2025

The 100-stock largecap basket of Mutual funds (MFs) has seen a major reshuffle in the latest semi-annual reclassification with seven midcap stocks and four new listings earning the largecap tag. According to a report from Nuvama Alternative & Quantitative Research, the midcap stocks that have been upgraded include CG Power, Rail Vikas Nigam, ICICI Prudential Life Insurance, Polycab India, Indus Towers, Cummins India, and Info Edge.

Ketan Parekh among 3 banned from securities markets

Ketan Parekh among 3 banned from securities markets

Rediff.com3 Jan 2025

The Securities and Exchange Board of India (Sebi) on Thursday debarred Ketan Parekh, the stock market operator involved in the stock market scam of 2000, Singapore-based trader Rohit Salgaocar, and one other individual from the securities market for alleged front-running of trades of a United States (US)-based foreign portfolio investor (FPI). The FPI manages around $2.5 trillion worth of funds globally.

Lower input costs may aid pharma firms' Q2 margins

Lower input costs may aid pharma firms' Q2 margins

Rediff.com21 Oct 2024

Analysts are expecting pharmaceutical companies to post sales growth of 10-11 per cent in the second quarter this financial year while the Ebitda (earnings before interest, tax, depreciation, and amortisation) margins are anticipated to improve by about 110 basis points. Ebitda improvement will be led by lower input costs because prices of active pharmaceutical ingredients (APIs) are 5-15 per cent lower year-on-year (Y-o-Y). Axis Capital said sales growth would be around 10 per cent, of which growth in the India market would be 11 per cent or so.

ITC Hotels' demerger to mirror Reliance Industries-Jio Financial playbook

ITC Hotels' demerger to mirror Reliance Industries-Jio Financial playbook

Rediff.com2 Jan 2025

ITC's move to hive off its hotel business will have implications for passive funds and exchange traded funds (ETFs) similar to that seen during the Reliance Industries-Jio Financial demerger. As ITC is part of popular indices such as Nifty and Sensex, it is held by several index funds and ETFs.

Celebs who bought OYO shares in recent months

Celebs who bought OYO shares in recent months

Rediff.com12 Jan 2025

Actors Madhuri Dixit, Amrita Rao, and Bollywood producer Gauri Khan are among celebrities who bought shares of travel tech platform OYO over the past few months. Gauri Khan bought 2.4 million shares of OYO during the recent Series G funding round concluded in August 2024 where the company raised over Rs 1,400 crore from a consortium of investors, sources told PTI.

Proposed RBI norms may hit gold-loan NBFCs in near term: Analysts

Proposed RBI norms may hit gold-loan NBFCs in near term: Analysts

Rediff.com21 Apr 2025

The Reserve Bank of India's (RBI's) draft guidelines on gold loans, if implemented in their current form, are expected to impact non-banking financial companies (NBFCs) and mid-tier banks in the near term, more significantly than larger banks, according to analysts.

Brokerages split after JSW Steel Q3 results miss estimates

Brokerages split after JSW Steel Q3 results miss estimates

Rediff.com28 Jan 2025

Steel maker JSW Steel's Q3 results, announced on January 24, 2025, after market hours, failed to meet Street expectations. The company reported a consolidated net profit attributable to the owners of Rs 717 crore in Q3FY25, reflecting a 70.3 per cent decline Y-o-Y, compared to Rs 2,415 crore in Q3FY24.

Why brokerages have revised their target prices for DMart

Why brokerages have revised their target prices for DMart

Rediff.com14 Jan 2025

Brokerages on DMart Q3 results: Avenue Supermarts (DMart) shares slipped as much as 5.74 per cent to hit an intraday low of Rs 3,474 per share on Monday. However, the stock recovered slightly to close at Rs 3,507.95, down 4.82 per cent. Notably, the 52-week low for DMart shares is Rs 3,400. The downward movement in DMart's share price was triggered by the company's 2024-25 (FY25) October-December quarter (Q3) results, which missed Street expectations.

How Much Have MFs Invested In HDFC Bank?

How Much Have MFs Invested In HDFC Bank?

Rediff.com16 Aug 2024

With a deployment of Rs 2,720 crore in July, MFs' total investment in HDFC Bank in calendar year 2024 (till now) surged to Rs 48,820 crore.

Auto revenue may hit high gear on rural push, launches

Auto revenue may hit high gear on rural push, launches

Rediff.com28 Jan 2025

Overall, volume growth is likely to be in the range of 3-8 per cent for two-wheelers and 5-7 per cent for passenger vehicles owing to healthy demand from urban and rural areas and pending order books.

How ITC plans to build a future-ready portfolio

How ITC plans to build a future-ready portfolio

Rediff.com6 May 2025

There remains a debate on who said this: "When the facts change, I change my mind. What do you do, Sir?" Was it the British economist John Maynard Keynes or the American economist Paul Samuelson. Irrespective of who said it, this sentiment appears to have found resonance in ITC's boardroom in recent years.

Most brokerages lift targets for UltraTech Cement

Most brokerages lift targets for UltraTech Cement

Rediff.com26 Jan 2025

Although UltraTech Cement's results for the December quarter of the current financial year (Q3FY25) were not an improvement compared to Q3FY24, the company managed to surpass Street expectations. The company's profit attributable to the owners of the parent dropped 17.4 per cent year-on-year (Y-o-Y) to Rs 1,469.5 crore in Q3FY25 as against Rs 1,777 crore in Q3FY24.

O2C biz may drag RIL to another weak quarter

O2C biz may drag RIL to another weak quarter

Rediff.com9 Oct 2024

For Reliance Industries Ltd (RIL), the September 2024 quarter (Q2FY25) may turn out to be yet another weak one as refining margins drag, say analysts. Two brokerage firms - ICICI Securities and Nuvama - expect a 1-13 per cent dip in reported profits in Q2FY25 from a year ago. Kotak Institutional expects a modest 2.2 per cent rise. Revenue, at best based on available analyst estimates, could rise up to 4 per cent.

Amfi stock reclassification: Largecap cutoff likely to touch Rs 1 trn

Amfi stock reclassification: Largecap cutoff likely to touch Rs 1 trn

Rediff.com18 Dec 2024

The market capitalisation (mcap) cutoff to qualify for mutual funds' (MFs') largecap universe is likely to go up for the fifth consecutive time to touch the Rs 1 trillion mark for the first time. A fresh list of largecap, midcap, and smallcap stocks is set to be released by the Association of Mutual Funds in India (Amfi) in the first week of January.

India's cement sector sees a concrete 2024 with over 10 major deals

India's cement sector sees a concrete 2024 with over 10 major deals

Rediff.com23 Dec 2024

With over 10 deals announced in 2024, the cement sector logged the highest number of pacts, including acquisitions and fresh financial investments, in a single calendar year since 2014, with the combined value of investments over $3.5 billion. During the year so far, 11 deals have been announced, according to Bloomberg data.

Analysts eye 34% upside in RIL post Q3; Jefferies, Citi, CLSA, MS upbeat

Analysts eye 34% upside in RIL post Q3; Jefferies, Citi, CLSA, MS upbeat

Rediff.com18 Jan 2025

India's most valued company, Reliance Industries Ltd (RIL), reported a robust performance in the third quarter of the current financial year (Q3FY25), surpassing analyst expectations. This coupled with positive commentary by brokerages led to the stock of the oil-to-telecom conglomerate surging as much as 4.44 per cent to hit an intraday high of Rs 1,325.1. It settled at Rs 1,301.3 apiece, up 2.57 per cent.

Sunny skies for Reits, with a high chance of growth

Sunny skies for Reits, with a high chance of growth

Rediff.com5 Nov 2024

After lagging behind benchmarks and broader indices over the past five years, real estate investment trusts (Reits) have outperformed them since the start of 2024. The four listed Reits have posted an average return of 16 per cent year-to-date, compared to 9.9 per cent for the S&P BSE Sensex and 11 per cent for the National Stock Exchange Nifty.

Health care, pharma IPOs raise Rs 14,811 cr in 2024

Health care, pharma IPOs raise Rs 14,811 cr in 2024

Rediff.com23 Dec 2024

India's healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding global opportunities. According to data, key contributors to the record fundraising included Sai Life Sciences (Rs 3,043 crore), IKS Health (Rs 2,498 crore), and Sagility India (Rs 2,107 crore).

Crompton Greaves Consumer may underperform on demand concerns

Crompton Greaves Consumer may underperform on demand concerns

Rediff.com6 Oct 2024

The stock of Crompton Greaves Consumer Electricals has shed about 12 per cent since the start of the month due to a muted near-term outlook. Demand slowdown across segments and pre-buying in cooling products in the June quarter are expected to weigh on revenues going ahead. In addition to pre-buying in the preceding quarter, demand conditions are soft on account of lower consumer spending due to inflationary conditions, weakness in rural demand and the fact that Q2 remains a soft quarter after a strong summer.

What Is A Front-Running Scam?

What Is A Front-Running Scam?

Rediff.com4 Jan 2025

Front-running is a fraudulent practice where traders exploit advance knowledge of large client orders for personal profit.

Voltas' margins need to match growth trajectory for further gains

Voltas' margins need to match growth trajectory for further gains

Rediff.com28 Nov 2024

After a strong show during the September quarter (Q2FY25) and favourable demand conditions, going ahead, the country's largest player in the room air conditioner segment, Voltas is well placed to improve its market share. Expectations of record volumes in FY25 for the sector and the company's strategy of prioritising market share over margins could help the leader expand share in the room AC segment.

Why Havells India stock is likely to lose spark

Why Havells India stock is likely to lose spark

Rediff.com29 Jan 2025

Havells India, the country's largest listed consumer electrical company, reported a mixed performance in the 2024-25 (FY25) October-December quarter (Q3). While the top line benefited from festival demand, lower margins impacted operational performance.

Private sector banks' credit costs up in Q3FY25 on higher provisions

Private sector banks' credit costs up in Q3FY25 on higher provisions

Rediff.com27 Jan 2025

Private sector banks that announced their earnings for the October-December quarter (Q3) of 2024-25 (FY25) reported a rise in credit costs due to higher provisions, mainly for unsecured retail loans.

Prosperity Is Not India's Birth Right

Prosperity Is Not India's Birth Right

Rediff.com30 Nov 2024

If growth reverts to the pre-Covid level, a lot of people may have to temper their rosy optimism, points out Debashis Basu.